Return On Equity of 60 DEGREES PHARMACEUTICALS, INC. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
60 DEGREES PHARMACEUTICALS, INC. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • 60 DEGREES PHARMACEUTICALS, INC. Return On Equity for the quarter ending 30 Sep 2025 was -217%, a 43% decline year-over-year.
  • 60 DEGREES PHARMACEUTICALS, INC. annual Return On Equity for 2024 was -159%, a 467% decline from 2023.
  • 60 DEGREES PHARMACEUTICALS, INC. annual Return On Equity for 2023 was 43%, a 52% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

60 DEGREES PHARMACEUTICALS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -217% -65% -43% 01 Jul 2025 30 Sep 2025
Q2 2025 -192% -163% -553% 01 Apr 2025 30 Jun 2025
Q1 2025 -243% -289% -618% 01 Jan 2025 31 Mar 2025
Q4 2024 -159% -202% -467% 01 Oct 2024 31 Dec 2024
Q3 2024 -152% 01 Jul 2024 30 Sep 2024
Q2 2024 -29% 01 Apr 2024 30 Jun 2024
Q1 2024 47% 01 Jan 2024 31 Mar 2024
Q4 2023 43% 01 Oct 2023 31 Dec 2023

60 DEGREES PHARMACEUTICALS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -159% -202% -467% 01 Jan 2024 31 Dec 2024
2023 43% +15% +52% 01 Jan 2023 31 Dec 2023
2022 29% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.